Lead Product(s) : Estriol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Estriol is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Atrophic Vaginitis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 12, 2019
Lead Product(s) : Estriol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Estriol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Vulvovaginal Atrophy Correction Using Neodymium Laser
Details : Estriol is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Postmenopause.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 03, 2021
Lead Product(s) : Estriol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Estriol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Estriol is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Atrophic Vaginitis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 05, 2020
Lead Product(s) : Estriol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Estriol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase I
Sponsor : SocraTec R&D GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Estriol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Menopause.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 06, 2017
Lead Product(s) : Estriol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase I
Sponsor : SocraTec R&D GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Estriol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase I
Sponsor : SocraTec R&D GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Estriol and Trimegestone Dose-response Trial With Single Dose Application of Vaginal Rings
Details : Estriol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Pregnancy.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 17, 2017
Lead Product(s) : Estriol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase I
Sponsor : SocraTec R&D GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Estriol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Estriol is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Atrophic Vaginitis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 18, 2016
Lead Product(s) : Estriol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Estriol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase II
Sponsor : Spanish Breast Cancer Research Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Estriol is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Atrophic Vaginitis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 09, 2015
Lead Product(s) : Estriol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase II
Sponsor : Spanish Breast Cancer Research Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Estriol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Estriol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Atrophic Vaginitis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 10, 2011
Lead Product(s) : Estriol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
Aspen API. More than just an API™
